January 28, 2025

Ocubio Sets New Standard in Eye Care with Launch of Personalized Ocular Therapies

Miami, FL – February 3rd, 2025 – Ocubio, an innovative pharmaceutical company focused on transforming eye care, is proud to introduce itself to the market as a pioneering leader in ocular personalized medicine. With a vision to enhance patient outcomes and improve the quality of life for individuals with ocular surface disorders, Ocubio is poised to revolutionize the field with its cutting-edge therapies.

Founded by a team of experts in ophthalmology and biotechnology, Ocubio combines the latest advancements in science with patient-centered care. The company’s mission is to address the growing need for effective, personalized treatments for ocular conditions such as dry eye disease, autoimmune-related eye disorders, and post-surgical recovery.

Ocubio’s flagship product, OB-1, an allogeneic human blood plasma-based eye drop treatment, is set to become a game-changer in the field of dry eye disease. Developed at the prestigious Bascom Palmer Eye Institute, OB-1 harnesses the therapeutic potential of human plasma to restore and support ocular surface health. This revolutionary product aims to offer an effective alternative to current dry eye treatments, focusing on long-term relief and healing through the natural healing properties found in plasma.

Dr. Alfonso L. Sabater, CEO of Ocubio, commented, “We are extremely excited to introduce Ocubio to the world. Our goal is to bring highly effective, personalized, and accessible eye care solutions to those in need. With products like OB-1, we are not just treating symptoms but addressing the underlying causes of dry eye disease, ultimately improving the lives of patients globally.”

Ocubio is committed to advancing the science of personalized eye care. The company plans to begin a soft launch of its autologous therapies in February, with broader commercial availability scheduled for mid-2025. With an established partnership pipeline, Ocubio is on track to deliver its therapies to thousands of patients in need each year.

For more information about Ocubio and its innovative ocular solutions, please visit ocubio.com or contact info@ocubio.com.

About Ocubio

Ocubio is a pharmaceutical company at the forefront of ocular personalized medicine. By combining the latest scientific advancements with a deep understanding of patient needs, Ocubio is developing breakthrough therapies designed to improve eye health and patient quality of life. The company’s focus is on creating effective, individualized treatments for a wide range of ocular surface diseases.